Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic
Hepatitis C Patients|
growing body of evidence indicates that liver
steatosis (fat accumulation) is associated with the metabolic syndrome, characterized
by abnormal blood lipid levels, type
2 diabetes, obesity, and high blood pressure.
has shown that presence of liver steatosis according to biopsy
is a risk factor for the development of hepatocellular
carcinoma (HCC) in chronic hepatitis C patients
with cirrhosis, but it
is unclear whether the specific clinical correlates of the metabolic syndrome
play a role.
reported at the Digestive Disease Week (DDW 2009) annual
meeting last week in Chicago, Bhavna Malik and colleagues sought to determine
whether the presence of clinical risk factors for non-alcoholic fatty liver disease
(NAFLD) -- i.e., obesity, type 2 diabetes, hypertriglyceridemia (elevated triglycerides),
and hypertension (high blood pressure) -- in people with hepatitis C increases
the risk of progression to HCC.
investigators conducted a retrospective chart review that included 76 case patients
with hepatitis C who received liver transplants at a single institution between
2000 and 2008 and had biopsy confirmed HCC. These patients were matched 1:1 on
the basis of age and sex with a cohort of control hepatitis C patients without
HCC who received transplants during the same period. Most participants (about
80%) were men and the mean age was 55 years.
researchers compared the percentage of patients in the 2 groups with body mass
index (BMI) greater than 30, triglyceride level above 150 mg/dL, blood glucose
level above 100 mg/dL, and blood pressure above 130/85.
Rates of obesity were the same in the groups with and without HCC, at 33%.
Fewer patients with HCC had diabetes compared to those without HCC (22% vs 33%).
Patients with HCC had a higher rate of hypertension (22%) compared with the control
The HCC group also had a higher rate of hypertriglyceridemia (28%) compared with
the controls (12%).
The mean triglyceride level for the patients with HCC was 127.64 mg/dL versus
100.11 mg/dL -- barely above the cut-off -- for those without HCC (P < 0.05).
this case control study, patients with HCV and HCC had higher rates of hypertension
and hypertriglyceridemia than patients with HCV alone," the researchers concluded.
"Other factors of the metabolic syndrome were not seen more commonly in patients
research is needed to determine the impact of hypertension and hypertriglyceridemia
on patients with HCV and their risk of progression to HCC," they added.
a related study presented at the recent 44th Annual Meeting of the European Association
for the Study of the Liver (EASL 2009), researchers
reported that metabolic syndrome was associated with a higher overall mortality
rate and a higher risk of liver-related death in chronic hepatitis C patients.
Medicine, South of Market Health Center, San Francisco, CA; GI/Hepatology, California
Pacific Medical Center, San Francisco, CA.
Malik and C Frenette. Metabolic Syndrome and Risk for Progression to Hepatocellular
Carcinoma in Patients with Hepatitis C Cirrhosis. Digestive Disease Week (DDW
2009). Chicago. May 30-June 4, 2009. Abstract M1775.